These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 343902)

  • 21. [Changes in the level of humoral response for measles virus in patients with subacute sclerotic panencephalitis during 1984-1989].
    Gut W
    Med Dosw Mikrobiol; 1992; 44(3-4):173-85. PubMed ID: 1305922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated cytotoxicity against measles virus in SSPE. I. Enhancement by antibody.
    Kreth HW; Meulen V
    J Immunol; 1977 Jan; 118(1):291-5. PubMed ID: 830752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis and its etiopathogenesis.
    Panelius M
    Med Biol; 1975 Aug; 53(4):187-94. PubMed ID: 1186317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of patient age and year of developing the disease on immunologic response to measles virus in subacute sclerosing panencephalitis (SSPE)].
    Gut W; Kowalewska A
    Med Dosw Mikrobiol; 1993; 45(4):503-10. PubMed ID: 8189831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interpretation of the results of identification of measles virus antibodies in the serum and cerebrospinal fluid from patients with suspected subacute sclerosing panencephalitis (SSPE)].
    Gut W; Panfist A
    Med Dosw Mikrobiol; 1991; 43(3-4):145-52. PubMed ID: 1823377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles virus-specific immunoglobulin D antibody in cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis and multiple sclerosis.
    Patrick BA; Mehta PD; Sobczyk W; Kulczycki J; Woyciechowska-Camenga J; Camenga D; Thormar H
    J Neuroimmunol; 1990 Jan; 26(1):69-74. PubMed ID: 2294143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE.
    Trudgett A; Bellini WJ; Mingioli ES; McFarlin DE
    Clin Exp Immunol; 1980 Mar; 39(3):652-6. PubMed ID: 6991172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin G subclass antibodies to measles virus in patients with subacute sclerosing panencephalitis or multiple sclerosis.
    Mehta PD; Patrick BA; Sobczyk W; Kulczycki J; Woyciechowska-Camenga J; Camenga D; Thormar H
    J Clin Microbiol; 1989 Jan; 27(1):62-5. PubMed ID: 2913037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligoclonal immunoglobulins in subacute sclerosing panencephalitis and multiple sclerosis: a study of idiotypic determinants.
    Ebers GC; Zabriskie JB; Kunkel HG
    Clin Exp Immunol; 1979 Jan; 35(1):67-75. PubMed ID: 85508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles virus persistency and disease.
    ter Meulen V; Carter MJ
    Prog Med Virol; 1984; 30():44-61. PubMed ID: 6379751
    [No Abstract]   [Full Text] [Related]  

  • 32. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles virus polypeptide-specific antibody profile in multiple sclerosis.
    Dhib-Jalbut S; Lewis K; Bradburn E; McFarlin DE; McFarland HF
    Neurology; 1990 Mar; 40(3 Pt 1):430-5. PubMed ID: 2314583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis.
    Steele RW; Fuccillo DA; Hensen SA; Vincent MM; Bellanti JA
    J Pediatr; 1976 Jan; 88(1):56-62. PubMed ID: 812971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles-specific IgG in CSF and serum from patients with subacute sclerosing panencephalitis.
    Mehta PD; Patrick BA; Thormar H
    Immunology; 1982 Jun; 46(2):423-8. PubMed ID: 7084997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immunity in subacute sclerosing panencephalitis.
    Livni E; Kott E; Danon Y; Kuritzky A; Joshua H
    Isr J Med Sci; 1976 Oct; 12(10):1183-8. PubMed ID: 791299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of antibodies against measles virus and myelin by in vitro stimulated B-cells derived from patients with subacute sclerosing panencephalitis.
    Wirguin I; Steinitz M; Sicsic C; Abramsky O; Brenner T
    Immunol Lett; 1993 Sep; 38(1):55-8. PubMed ID: 7507883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous cytotoxicity against measles virus infected and K562 cells in normal subjects and subacute sclerosing panencephalitis.
    Sanal O; Ustaçelebi S; Başaran M; Aysun S; Ersoy F; Berkel AI
    Boll Ist Sieroter Milan; 1985; 64(5):400-3. PubMed ID: 4091977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles.
    Hankins RW; Black FL
    J Clin Microbiol; 1986 Sep; 24(3):324-9. PubMed ID: 3531224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal production of measles-specific IgA in subacute sclerosing panencephalitis.
    Visudtibhan A; Mehta PD; Kulczycki J; Coyle PK; Thormar H
    Acta Neurol Scand; 1997 Aug; 96(2):97-100. PubMed ID: 9272185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.